Product Information
BEPREVE 1.5% EYE DROPS is a brand product labeled by Bausch & Lomb Incorporated, priced at $55.9357 per ML under NDC 24208062902. Its NADAC has been published 649 times since Mar 19, 2014.
FDA first approved this application on Sep 8, 2009. Its Orange Book therapeutic-equivalence code is AT.
The High Outlier badge above means this manufacturer's average price in the bepotastine besilate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
15 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208062902
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
3/18/2026
Active Ingredients
BEPOTASTINE BESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA022288FDA Approved
9/8/2009
TE Code
AT
On Market Since
9/8/2009
Pharmacological Classes
Price Statistics
The NADAC for BEPREVE 1.5% EYE DROPS has been published 649 times since Mar 19, 2014, and over the history we have for it it has risen 92.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $55.9357 per ML |
|---|---|
| All-time high | $56.0123 (May 14, 2025) |
| All-time low | $29.0226 (Mar 19, 2014) |
| 52-week high | $55.9887 |
| 52-week low | $55.9357 |
| Median price | $44.1407 |
| Average price | $43.8161 |
| Largest weekly change | +9.7% (Mar 18, 2015) |
| Weeks tracked | 649 |
| Tracking since | Mar 19, 2014 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 85% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BEPREVE 1.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for BEPREVE 1.5% EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $55.9357 per ML (NDC 24208062902), effective Aug 19, 2026.
How has the price of BEPREVE 1.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for BEPREVE 1.5% EYE DROPS has risen 92.7%. It has been tracked across 649 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for BEPREVE 1.5% EYE DROPS?
Since Mar 19, 2014, the NADAC for BEPREVE 1.5% EYE DROPS has ranged from a low of $29.0226 (Mar 19, 2014) to a high of $56.0123 (May 14, 2025), with a median of $44.1407 per ML.
Are there cheaper alternatives to BEPREVE 1.5% EYE DROPS?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BEPOTASTINE 1.5% EYE DROP, is $8.3591 per ML — about 85% below BEPREVE 1.5% EYE DROPS.
Who manufactures BEPREVE 1.5% EYE DROPS?
BEPREVE 1.5% EYE DROPS (NDC 24208062902) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a brand product.